← Open Payments lookup

KATE BROWNE: Open Payments

NPI 1942956735 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$597 in 25 payments from 10 companies in 2025. Trend: 2023 $305 · 2024 $400 · 2025 $597

Food & beverage: $504Education: $93
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation11$210
Incyte Corporation1$93
AstraZeneca Pharmaceuticals LP3$68
Boehringer Ingelheim Pharmaceuticals, Inc.2$50
Celgene Corporation2$48
Adaptive Biotechnologies Corporation2$34
E.R. Squibb & Sons, L.L.C.1$29
ABBVIE INC.1$29
Immunocore Limited1$20
BeiGene USA, Inc.1$18

Products named: KISQALI, REBLOZYL, IMFINZI, SCEMBLIX, clonoSEQ, EPKINLY, PLUVICTO, LUTATHERA.

Industry payments across IL — which companies pay providers there.